Dudediligence.

Turn Therapeutics Inc

TTRXNASDAQ · Pharmaceutical Preparations
Write an idea

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

29.8M

on 2026-06-30, from 28.0M on 2025-09-30 10-Q ↗

Newest

None

No S-3 or F-3 shelf on file in the last 30 months.

None

No at-the-market programme on file in the last 30 months.

Warrants

1.19M

Warrants of every class as tagged in the XBRL facts on 2026-06-30, exercise price $5.03. 10-Q ↗

Cash

9.2 quarters

$9.9M on 2026-06-30 ÷ $1.1M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised: 1 of its filings are not read yet.

Also on file: up to $25.0M term loans agreed 2026-03-24 8-K ↗